Survival from breast cancer in England and Wales up to 2001
2008
Breast cancer survival in England and Wales
publication
Evidence: moderate
Author Information
Author(s): Leary A, Smith I E
Primary Institution: Breast Unit, Royal Marsden Hospital, NHS Foundation Trust
Conclusion
Improvements in breast cancer diagnosis and treatment in the UK have significantly impacted survival rates.
Supporting Evidence
- Breast cancer mortality has decreased by 20% in the UK over the last 20 years.
- Screening has increased the incidence of ductal carcinoma in situ, which may lead to overdiagnosis.
- Access to specialist surgeons improves survival rates for early breast cancer patients.
- Adjuvant therapies like tamoxifen and chemotherapy have shown significant survival benefits.
- New treatments for metastatic breast cancer have improved survival times.
Takeaway
Breast cancer survival has improved in the UK due to better treatments and awareness, but there are still challenges in ensuring all women get the best care.
Limitations
The study does not address the disparities in survival rates among different socioeconomic groups.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website